Troponin I as a predictor for trastuzumab-related cardiotoxicity: Current data do not provide mechanistic insights or allow for incorporation into clinical practice

Journal of Clinical Oncology

Volumn 29, Issue 7, 2011, Pages

  Goel, Shom ^a,b   Beith, Jane M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; LAPATINIB; TRASTUZUMAB; TROPONIN I;

CARDIOTOXICITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HUMAN; LETTER; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HEART; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SURVIVAL ANALYSIS; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79952344767     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.7353     Document Type: Letter

References (10)

1. Cardinale D, Colombo A, Torrisi R, et al: Trastuzumab-induced cardiotoxicity: Clinical and prognostic implications of troponin I evaluation. J Clin Oncol 28:3910-3916, 2010
2. Rastogi P, Jeong J, Geyer CE, et al: Five year update of cardiac dysfunction on NSABP B-31, a randomized trial of sequential doxorubicin/ cyclophosphamide (AC)3paclitaxel (T) compared to AC→T with trastuzumab(H). J Clin Oncol 25:6s, 2007 (suppl; abstr LBA513)
3. Kelley WE, Januzzi JL, Christenson RH: Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 55:2098-2112, 2009
4. Horwich TB, Patel J, MacLellan WR, et al: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108:833-838, 2003 (Pubitemid 37022125)
5. King DA, Codish S, Novack V, et al: The role of cardiac troponin I as a prognosticator in critically ill medical patients: A prospective observational cohort study. Crit Care 9:R390-R395, 2005
6. John J, Woodward DB, Wang Y, et al: Troponin-I as a prognosticator of mortality in severe sepsis patients. J Crit Care 25:270-275, 2010
7. Janata KM, Leitner JM, Holzer-Richling N, et al: Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism. Eur Respir J 34:1357-1363, 2009
8. Chien KR: Stress pathways and heart failure. Cell 98:555-558, 1999
9. Perez EA, Koehler M, Byrne J, et al: Cardiac safety of lapatinib: Pooled analysis of 3689 patients enrolled in clinical trials. Mayo Clin Proc 83:679-686, 2008 (Pubitemid 351810568)
10. Force T, Krause DS, Van Etten RA: Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 7:332-344, 2007 (Pubitemid 46652481)